Animal NDC 46066-802-50 Calcium Gluconate 23% Solution

Calcium Gluconate 23% Solution Images

Calcium Gluconate 23% Solution Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



General Precautions



For Animal Use Only


Otc - Keep Out Of Reach Of Children



Keep Out of Reach of Children


Information For Owners/Caregivers



NET CONTENTS: 500 mL (16.91 fl oz)

STERILE

Manufactured for:
Aspen Veterinary ResourcesR ,Ltd.
Liberty, MO 64068 USA

www. aspenveterinaryresources.com                     A140NVT 02/24

18-802   RMS# 92-503

Lot No.           Exp. Date

NDC# 46066-802-50


Indications:



For use in cattle as an aid in treating
uncomplicated milk fever (parturient paresis).


Dosage And Administration:



For intravenous administration only.
Cattle...............250-500 mL
Dosage may be repeated at 8 to 12 hour intervals
if required.


Caution:



Solution should be warmed to body temperature
and administered slowly. Entire contents should
be used upon entering, as this product contains
no preservative. Discard any unused
portion. Do not use if solution is cloudy
or contains precipitate.


Note:



Monitor animal's condition closely. Re-treatment
may be necessary. If there is no noticeable
improvement within 24 hours following
treatment, consult your veterinarian. Aseptic
precautions should be observed.


Each 500 Ml Contains:



Active Ingrdients:

Calcium Gluconate................23% w/v
(provides 10.71 g of Calcium* per
500 mL)


Inactive Ingredients:



Water for Injection.......................q.s.
Contains boric acid as solubilizing agent.


Storage And Handling



Store between 15°C - 30°C (59°F - 86°F).


Precautions



TAKE TIME OBSERVE LABEL DIRECTIONS


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.